commercial innovative drug catalog

National Reimbursement Drug List

Breaking: NHSA Releases Preliminary Review Results for 2025 National Reimbursement Drug List and Commercial Innovative Drug Catalog

On August 12, 2025, NHSA published the initial review results for China’s 2025 NRDL and Commercial Innovative Drug List, marking the first step toward expanded reimbursement access for innovative therapies.